Joshua S. Prince

Chief Operating Officer, Vistagen Therapeutics, Inc.

Companies

Vistagen Therapeutics, Inc.Chief operating officer Nov 3, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vistagen Therapeutics, Inc. VTGN15,249 shares²$3.1K at $0.20Dec 31, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 31, 2025Granted 4,386 shares at $0.56 of Vistagen Therapeutics, Inc.²
Jun 30, 2025Granted 4,882 shares at $1.70 of Vistagen Therapeutics, Inc.³
Dec 31, 2024Granted 3,310 shares at $2.51 of Vistagen Therapeutics, Inc.⁴
Jun 28, 2024Granted 2,671 shares at $2.96 of Vistagen Therapeutics, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVistagen Therapeutics, Inc., Chief operating officer
2
SEC EDGARVistagen Therapeutics, Inc. shares after the filing of Dec 31, 2025
3
SEC EDGARForm 4 filed Jul 1, 2025
4
SEC EDGARForm 4 filed Jan 13, 2025
5
SEC EDGARForm 4 filed Jul 2, 2024